List of Subject Classifications Records

Browse Results (71 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

 Browse by Research Fields, Courses and Disciplines The Research Fields, Courses and Disciplines (Australian Standard Research Classification) is published by the Australian Bureau of Statistics (ABS catalogue number 1297.0) 1998. ABS data is used with permission from the Australian Bureau of Statistics -> 320000 Medical and Health Sciences -> 320200 Immunology -> 320206 Tumor Immunology :

No further child subject classifications could be found.
  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Khanna, R., Bell, S., Sherritt, M., Galbraith, A., Burrows, S. R., Rafter, L., Clarke, B., Slaughter, R., Falk, M. C., Douglass, J., Williams, T., Elliott, S. L. and Moss, D. J. (1999) Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proceedings of the National Academy of Sciences of the United States of America, 96 18: 10391-10396. doi:10.1073/pnas.96.18.10391 92   203 Cited 225 times in Scopus225 0
Nieda, M., Nicol, A. J., Koezuka, Y., Kikuchi, A., Takahashi, T., Nakamura, H., Furukawa, H., Yabe, T., Ishikawa, Y., Tadokoro, K. and Juji, T. (1999) Activation of human Valpha24NKT cells by alpha-glycoslceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Human Immunology, 60 1: 10-19. doi:10.1016/S0198-8859(98)00100-1 45   84 Cited 88 times in Scopus88 0
Stewart, Trina Jane. (2002). Adoptive immunotherapy studies of HPV16E7-expressing tumours PhD Thesis, School of Medicine, The University of Queensland. 210 2
Sculley, T. B., Buck, M., Gabrielli, B., Parsons, P. G. and Krauer, K. G. (2002) A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus-transformed B-cell lines - A potential therapy for posttransplant lymphoproliferative disease. Transplantation, 73 2: 271-279. doi:10.1097/00007890-200201270-00021 126   11 Cited 11 times in Scopus11 0
Lin, H, Nieda, M, Rozenkov, V and Nicol, AJ (2006) Analysis of the effect of different NKT cell subpopulations on the activation of CD4 and CD8 T cells, NK cells, and B cells. Experimental Hematology, 34 3: 289-295. doi:10.1016/j.exphem.2005.12.008 80   15 Cited 17 times in Scopus17 0
Mateo, L. A., Gardner, J., Chen, Q. Y., Schmidt, C., Down, M., Elliott, S. L., Pye, S. J., Firat, H., Lemmonier, F. A., Cebon, J. and Suhrbier, A. (1999) An HLA-A2 polyepitope vaccine for malenoma immunotherapy. Journal of Immunology, 163 7: 4058-4063. 66   64
Juffs, Helen, Fowler, Nina, Saal, Russell, Grimmett, Karen, Beasley, Shannon, O'Sullivan, Brendan, Frazer, Ian H., Gill, Devinder and Thomas, Ranjeny (2004) B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon-gamma. Pathology, 36 1: 69-76. doi:10.1080/00313020310001644499 136   4 Cited 4 times in Scopus4 0
Troy, A. J., Davidson, P. J. T., Atkinson, C. H. and Hart, D. N. J. (1999) CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated. Journal of Urology, 161 6: 1962-1967. doi:10.1016/S0022-5347(05)68864-7 71   35 Cited 36 times in Scopus36 0
Monsonego, J, Bosch, FX, Coursaget, P, Cox, JT, Franco, E, Frazer, I, Sankaranarayanan, R, Schiller, J, Singer, A, Wright, T, Kinney, W, Meijer, C and Linder, J (2004) Cervical Cancer Control, Priorities and New Directions. International Journal of Cancer, 108 3: 329-333. doi:10.1002/ijc.11530 70   63 Cited 89 times in Scopus89 0
Lowy, Douglas R. and Frazer, Ian H. (2003) Chapter 16: Prophylactic Human Papillomavirus Vaccines. Journal of the National Cancer Institute Monographs, 31 31: 111-116. 76   Cited 64 times in Scopus64
Mattarollo, Stephen R., Kenna, Tony, Nieda, Mie and Nicol, Andrew J. (2007) Chemotherapy and zoledronate sensitize solid tumour cells to V γ9Vδ2T cell cytotoxicity. Cancer Immunology Immunotherapy, 56 8: 1285-1297. doi:10.1007/s00262-007-0279-2 587   58 Cited 66 times in Scopus66 0
Koppi, T, Munster, DJ, Brown, L, MacDonald, KPA and Hart, DNJ (2003) CMRF-44 antibody-mediated depletion of activated human dendridic cells: A potential means for improving allograft survival. Transplantation, 75 10: 1723-1730. doi:10.1097/01.TP.0000062569.40977.66 113   6 Cited 7 times in Scopus7 0
Lin, H., Nieda, M., Hutton, J. F., Rozenkov, V. and Nicol, A. J. (2006) Comparative gene expression analysis of NKT cell subpopulations. Journal of Leukocyte Biology, 80 1: 164-173. doi:10.1189/jlb.0705421 48   14 Cited 15 times in Scopus15 0
Wilson, W. M., Dua, U., Grigg, A. P. and Gandhi, M. K. (2006) Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma. Leukemia & Lymphoma, 47 5: 871-876. doi:10.1080/10428190600649562 79   4 Cited 6 times in Scopus6 0
Nicol, A. J., Kikuchi, A., Nieda, M., Hutchins, C., Horley, D., Henry, J. and Durrant, S. T. (1999). Cytotoxic T-Lymphocyte therapy for a patient with chronic myeloid leukaemia. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (65). 21 - 29 Oct, 1999. 28  
Giles, N., Henry, J., Horley, D. and Nicol, A. J. (1999). Dendritic cell (DC) therapy for patients with solid tumors. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (76). 21 - 27 Oct, 1999. 66  
Hart, D. N. J. and Hill, G. R. (1999) Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma. Immunology and Cell Biology, 77 5: 451-459. doi:10.1046/j.1440-1711.1999.00859.x 82   24 Cited 26 times in Scopus26 0
Peng, J. C., Thomas, R and Dredge, K. (2006) Dendritic cell immunotherapy for melanoma. Reviews on Recent Clinical Trials, 1 2: 87-102. doi:10.2174/157488706776876517 62   Cited 2 times in Scopus2 0
Nieda, M, Kikuchi, A, Nicol, A, Koezuka, Y, Ando, Y, Ishihara, S, Lapteva, N, Yabe, T, Tokunaga, K, Tadokoro, K and Juji, T (2001) Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4(+) V alpha 24 natural killer T cells expressing CD40L. Immunology, 102 2: 137-145. doi:10.1046/j.1365-2567.2001.01175.x 50   13 Cited 12 times in Scopus12 0
Yan, Mengyong, Peng, Judy, Abdul Jabbar, Ibtissam A., Liu, Xiaosong, Filgueira, Luis, Frazer, Ian H. and Thomas, Ranjeny (2004) Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Virology, 324 2: 297-310. doi:10.1016/j.virol.2004.03.045 119   42 Cited 45 times in Scopus45 0
Crough, T, Nieda, M, Morton, J, Bashford, J, Durrant, S and Nicol, AJ (2002) Donor-derived b2a2-specific T cells for immunotherapy of patients with chronic myeloid leukemia. Journal of Immunotherapy, 25 6: 469-475. doi:10.1097/00002371-200211000-00003 77   4 Cited 6 times in Scopus6 0
O'Rourke, Michael G. E., Johnson, Maree, Lanagan, Catherine, See, Janet, Yang, Jie, Bell, John R., Slater, Greg J., Kerr, Beverley M., Crowe, Beth, Purdie, David M., Elliott, Suzanne L., Ellem, Kay A. O. and Schmidt, Christopher W. (2003) Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine. Cancer Immunology Immunotherapy, 52 6: 387-395. doi:10.1007/s00262-003-0375-x 87   115 Cited 128 times in Scopus128 0
Tisdell, C. (2003) Economic globalisation, liberalisation and Bangladesh: Poverty, labour norms and the environment. South Asia-journal of South Asian Studies, 26 3: 269-282. doi:10.1080/0085640032000178880 43 2 0 Cited 0 times in Scopus0 0
Brown, R, Murray, A, Pope, B, Sze, DM, Gibson, J, Ho, PJ, Hart, D and Joshua, D (2004) Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta(1) in patients with myeloma. British Journal of Haematology, 125 6: 743-748. doi:10.1111/j.1365-2141.2004.04984.x 42   34 Cited 37 times in Scopus37 0
Gandhi, M. K. (2006) Epstein-Barr virus-associated lymphomas. Expert Review of Anti-Infective Therapy, 4 1: 77-89. doi:10.1586/14737140.4.1.77 36   Cited 19 times in Scopus19 0
Manders, Peter Matthew (2000). Expression of HPV16E7 as a possible mechanism of escape from a productive anti-E7 immune response PhD Thesis, School of Medicine, The University of Queensland. 76  
Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. and Khanna, R. (2006) Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients. Blood, 108 7: 2280-2289. doi:10.1182/blood-2006-04-015164 64   67 Cited 75 times in Scopus75 3
Packer, L. M., Williams, S. J., Callaghan, S., Gotley, D. C. and McGuckin, M. A. (2004) Expression of the cell surface mucin gene family in adenocarcinomas. International Journal of Oncology, 25 4: 1119-1126. 87   33 Cited 34 times in Scopus34
Malcolm, K. M., Gill, J., Leggatt, G. R., Boyd, R., Lambert, P. and Frazer, I. H. (2003) Expression of the HPV16E7 Oncoprotein by Thymic Epithelium is Accompanied by Disrupted T Cell Maturation and a Failure of the Thymus to Involute with Age. Clinical and Developmental Immunology, 10 2-4: 91-103. doi:10.1080/10446670310001626562 62   Cited 3 times in Scopus3 0
Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M. and Khanna, R. (2003) Ex vivo profiling of CD8(+)-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. Journal of Virology, 77 9: 5226-5240. doi:10.1128/JVI.77.9.5226-5240.2003 48   182 Cited 198 times in Scopus198 0
Vuckovic, S., Kim, M., Turtle, C. J., Khalil, D., Crosbie, G.V., Williams, K., Williams, N., Brown, L., Kelly, C., Stravos, P., Rodwell, R., Hill, G., Wright, S. J., Taylor, K., Gill, D., Marlton, P., Bradstock, K. and Hart, D. N. J. (2003) Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood, 101 6: 2314-2317. doi:10.1182/blood-2002-03-0973 105   38 Cited 38 times in Scopus38 0
Firat, Hüseyin, Garcia-Pons, Francisco, Tourdot, Sophie, Pascolo, S., Scardino, A., Garcia, Z., Michel, M., Jack, R. W., Jung, G., Kosmatopoulos, K., Mateo, Luis A., Suhrbier, Andreas, Lemmonier, F. A. and Langlade-Demoyen, P. (1999) H-2 class 1 knockout, HLA-A2.1 transgenic mice: A versatile animal model for preclinical evaluation of antitumour immunotherapeutic strategies. European Journal of Immunology, 29 10: 3112-3121. doi:10.1002/%28SICI%291521-4141%28199910%2929:10%3C3112%3A%3AAID-IMMU3112%3E3.0.CO%3B2-Q 57   136 Cited 139 times in Scopus139 0
Kato, Masato, Khan, Seema, Gonzalez, Nelson, O'Neill, Brian P., McDonald, Kylie J., Cooper, Ben J., Angel, Nicola Z. and Hart, Derek N. J. (2003) Hodgkin's lymphoma cell lines express a fusion protein encoded by intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) and a novel C-type lectin receptor DCL-1. Journal of Biological Chemistry, 278 36: 34035-34041. doi:10.1074/jbc.M303112200 101   28 Cited 26 times in Scopus26 3
Pinto, Ligia A., Castle, Philip E., Roden, Richard B., Harro, Clayton D., Lowy, Douglas R., Schiller, John T., Wallace, Dora, Williams, Marcus, Kopp, William, Frazer, Ian H., Berzofsky, Jay A. and Hildesheim, Allan (2005) HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine, 23 27: 3555-3564. doi:10.1016/j.vaccine.2005.01.146 134   35 Cited 40 times in Scopus40 1
Hock, B. D., Fearnley, D. B., Boyce, A., McLellan, A. D., Sorg, R. V., Summers, K. L. and Hart, D. N. J. (1999) Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens, 53 4: 320-334. doi:10.1034/j.1399-0039.1999.530402.x 48   44 Cited 47 times in Scopus47 0
Frazer, I. H. (2004). Human Papillomavirus. In Ciro A. de Quadros (Ed.), Vaccines: Preventing Disease & Protecting Health 1 ed. (pp. 140-143) Washington, D.C.: Pan American Health Organisation. 63  
Doan, Tracy, Herd, Karen, Street, Michael, Bryson, Gregory, Fernando, Germain, Lambert, Paul and Tindle, Robert (1999) Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles. Journal of Virology, 73 7: 6166-6170. 57   26
Okai, M, Nieda, M, Tazbirkova, A, Horley, D, Kikuchi, A, Durrant, S, Takahashi, T, Boyd, A, Abraham, R, Yagita, H, Juji, T and Nicol, A (2002) Human peripheral blood V alpha 24(+) V beta 11(+) NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. Vox Sanguinis, 83 3: 250-253. doi:10.1046/j.1423-0410.2002.00217.x 66   35 Cited 35 times in Scopus35 0
Nicol, A. J., Kikuchi, A., Nieda, M., Schmidt, C., Giles, N., Horley, D., Henry, J. and Durrant, S. T. (1999). Human Va24+ NKT cells have anti-tumour activity against human melanoma. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (65). 21 - 27 Oct, 1999. 48  
Liu, Xiao Song, Xu, Yan, Hardy, Lani, Khammanivong, Vithagna, Zhao, Weiming M., Fernando, Germain J. P., Leggatt, Graham R. and Frazer, Ian H. (2003) IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host. Journal of Immunology, 171 9: 4765-4772. 103   26 Cited 32 times in Scopus32
Thomas, R, Chambers, M, Boytar, R, Barker, K, Cavanagh, LL, MacFadyen, S, Smithers, M, Jenkins, M and Andersen, J (1999) Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy. Melanoma Research, 9 5: 474-481. doi:10.1097/00008390-199910000-00007 194   42 0
Frazer, I. H., Leippe, D. M., Dunn, L. A., Liem, A., Tindle, R. W., Fernando, G. J. P., Phelps, W. C. and Lambert, P. F. (1995) Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Cancer Research, 55 12: 2635-2639. 53 57 33 Cited 35 times in Scopus35
Tindle, R. W. (1999). Immunomodulation of HPV infection and disease. In Robert W. Tindle (Ed.), Vaccines for Human Papillomavirus Infection and Anogenital Disease 1st ed. (pp. 1-12) Texas, USA: R. G. Landes Company. 41  
O'Connor, V. M. (2003) Immunotherapy for HPV associated pre-cancer. Cancer Immunity, 3 S1: 25. 52  
Matsumoto, K., Leggatt, G. R., Zhong, J., Liu, X. S., De Kluyver, R. L., Peters, T., Fernando, G. J. P., Liem, A., Lambert, P. F. and Frazer, I. H. (2004) Impaired Antigen Presentation and Effectiveness of Combined Active/Passive Immunotherapy for Epithelial Tumors. Journal of the National Cancer Institute, 96 21: 1611-1619. doi:10.1093/jnci/dhj301 71   28 Cited 38 times in Scopus38 0
McLellan, A. D., Heiser, A. and Hart, D. (1999) Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activities.. Immunology, 98 2: 171-180. 25   18
Stewart, Trina J., Smyth, Mark J., Fernando, Germain J. P., Frazer, Ian H. and Leggatt, Graham R. (2003) Inhibition of early tumor growth requires Jα18-positive (natural killer T) cells. Cancer Research, 63 12: 3058-3060. 79   41 Cited 41 times in Scopus41
Barnard, P. (2000). Inhibition of Interferon signalling by human papillomavirus PhD Thesis, School of Medicine, The University of Queensland. 83  
Stewart, Trina J., Drane, Debbie, Malliaros, Jim, Elmer, Heidi, Malcolm, Karen M., Cox, John C., Edwards, Stirling J., Frazer, Ian H. and Fernando, Germain J. P. (2004) ISCOMATRIX (TM) adjuvant: An adjuvant suitable for use in anticancer vaccines. Vaccine, 22 27-28: 3738-3743. doi:10.1016/j.vaccine.2004.03.026 165   23 Cited 30 times in Scopus30 0
Frazer, I. H. (2004) Is vaccine therapy the future in cancer prevention?. Expert Opinion on Pharmacotherapy, 5 12: 2427-2434. doi:10.1517/14656566.5.12.2427 57   0 Cited 0 times in Scopus0 0

Page 1 of 2

Result Pages:    1 2  next › last »